+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Point-of-Care/Rapid Diagnostics Market by Testing (Glucose, Lipids, HbA1c, HCV, HIV, Influenza, Urinalysis, Hematology, Cancer, Pregnancy, PT/INR), Platform (Lateral Flow, Immunoassay), Mode (Prescription, OTC), End-User - Global Forecast to 2022

  • ID: 4464393
  • Report
  • Region: Global
  • 217 Pages
  • Markets and Markets
1 of 5
Point-of-Care/Rapid Diagnostics Market worth 38.13 Billion USD by 2022

FEATURED COMPANIES

  • Abbott
  • and Company
  • Chembio
  • Dickinson
  • Johnson & Johnson
  • PTS Diagnostics
  • MORE

The point-of-care diagnostics market projected to grow at a CAGR of 10.0%.

The global point-of-care diagnostics market is projected to reach USD 38.13 billion by 2022 from USD 23.71 billion in 2017, at a CAGR of 10.0%. High prevalence of infectious diseases in developing countries, increasing incidence of target diseases, and increasing inclination toward home healthcare across the globe are the factors expected to drive the market during the study period.

However, the lack of alignment with definitive central lab methods, certain disadvantages of POC testing over central lab methods, and the reluctance among physicians to change existing diagnostic practices are the key factors that are limiting the growth of this market.

The glucose monitoring products segment is expected to command the largest share of the POC diagnostics market in 2017.

On the basis of product, the glucose monitoring products segment is expected to command the largest share of the global POC diagnostics market in 2017. The large share of this segment can be attributed to the growing incidence and prevalence of diabetes across the globe and rising preference for home glucose testing.

The molecular diagnostics segment is expected to be the fastest-growing segment during the forecast period.

On the basis of platform, the market is segmented into lateral flow assays, dipsticks, microfluidics, molecular diagnostics, and immunoassays. The molecular diagnostics segment is expected to be the fastest-growing segment during the forecast period. Growing advancements in technology and increasing initiatives of market players for developing POC molecular diagnostic products is propelling the demand for molecular diagnostics.
 
Asia Pacific is expected grow at the highest CAGR during the forecast period.

Geographically, the point-of-care diagnostics market is segmented into North America, Europe, Asia Pacific, and RoW. Asia Pacific is expected to register the highest growth rate during the forecast period due to the growing initiatives by market players, increasing patient population base, and rising number of partnerships and joint ventures in this region.

Breakdown of supply-side primary interviews:

  • By Company Type - Tier 1 – 35%, Tier 2 – 45% and Tier 3 – 20%
  • By Designation – – C level – 15%, Director level – 30%, Others – 55%
  • By Region – North America - 45%, Europe – 20%, APAC – 30%, RoW – 5%

The major players of the point-of-care diagnostics market are Abbott (US), Roche (Switzerland), Siemens (Germany), Danaher (US), Becton, Dickinson, and Company (US), Johnson & Johnson (US), Instrumentation Laboratory (US), PTS Diagnostics (US), Quidel (US), Chembio (US), Sekisui Diagnostics (US), Nova (US), EKF Diagnostics (UK), AccuBioTech (China), and Trinity Biotech (US).

Research Coverage

This report studies the point-of-care diagnostics market based on product, platform, mode, end user, and region. The report also studies factors affecting market growth, it analyzes opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends. The report forecasts the revenue of market segments with respect to the four key regions and respective countries.

Reasons to Buy the Report:

From an insights perspective, this research report has focused on various levels of analysis— market ranking analysis of top players, and company profiles, which together comprise and discuss basic views on the competitive landscape, emerging segments of the point-of-care diagnostics market, and high-growth regions and their drivers, restraints, challenges, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, will help firms garner greater market shares.

Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott
  • and Company
  • Chembio
  • Dickinson
  • Johnson & Johnson
  • PTS Diagnostics
  • MORE

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.4 Markets Covered
1.4.1 Years Considered for the Study
1.5 Currency
1.6 Limitations
1.7 Stakeholders

2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Secondary Sources
2.1.2 Primary Data
2.1.2.1 Primary Sources
2.1.2.2 Key Industry Insights
2.1.3 Market Size Estimation Methodology
2.1.3.1 Bottom-Up Approach
2.1.3.2 Top-Down Approach
2.1.4 Research Design
2.1.5 Market Data Validation and Triangulation
2.1.6 Assumptions for the Study

3 Executive Summary
3.1 Introduction

4 Premium Insights
4.1 POC Diagnostics: Market Overview
4.2 POC Diagnostics Market, By Platform
4.3 Geographic Analysis: POC Diagnostics Market, By End User and Region
4.4 POC Diagnostics Market, By Product
4.5 POC Diagnostics Market, By Prescription Mode
4.6 Geographic Snapshot of the POC Diagnostics Market

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 High Prevalence of Infectious Diseases in Developing Countries
5.2.1.2 Increasing Incidence of Target Diseases
5.2.1.3 Rising Usage of Home-Based POC Devices
5.2.1.4 Growing Government Support
5.2.1.5 Technological Advancements and New Product Launches
5.2.1.6 Growing Number of Regulatory Approvals for Novel Immunoassay Techniques
5.2.1.7 Shortage of Skilled Laboratory Technicians
5.2.1.8 Rising Number of Clia-Waived POC Tests
5.2.2 Restraints
5.2.2.1 Product Recalls: Hampering User Confidence
5.2.2.2 Pricing Pressure Owing to Reimbursement Cuts and Budget Constraints
5.2.2.3 Stringent and Time-Consuming Regulatory Policies are Significantly Increasing Gestation Period for Product Launches
5.2.3 Opportunities
5.2.3.1 Growth Opportunities in Emerging Markets
5.2.3.2 Healthcare Decentralization —Converting Lab Tests to POC Tests
5.2.3.3 Increasing Number of Conferences and Events
5.2.3.4 POC Tests With Multiplexing Capabilities
5.2.4 Challenges
5.2.4.1 Lack of Alignment With Definitive Central Lab Methods
5.2.4.1.1 Disadvantages of POC Testing Over Central Lab Methods
5.2.4.2 Inadequate Knowledge About the Use of POC Devices in Professional Settings
5.2.4.3 Reluctance Towards Changing Existing Diagnostic Practices
5.2.4.4 High Cost of Devices
5.2.5 Emerging Applications of Point-of-Care Testing
5.2.5.1 Sepsis Biomarkers
5.2.5.2 Stroke Markers
5.2.5.3 Thyroid Testing
5.2.5.4 Dna Testing
5.2.5.5 Endocrine Testing

6 Point-of-Care Diagnostics Market, By Product
6.1 Introduction
6.2 Glucose Monitoring Products
6.2.1 Strips
6.2.2 Meters
6.2.3 Lancets & Lancing Devices
6.3 Cardiometabolic Testing Products
6.3.1 Cardiac Marker Testing Products
6.3.2 Blood Gas/Electrolytes Testing Products
6.3.3 HBA1C Testing Products
6.4 Infectious Disease Testing Products
6.4.1 Influenza Testing Products
6.4.2 HIV Testing Products
6.4.3 Hepatitis C Testing Products
6.4.4 Sexually Transmitted Disease (STD) Testing Products
6.4.5 Healthcare-Associated Infection (HAI) Testing Products
6.4.6 Respiratory Infection Testing Products
6.4.7 Tropical Disease Testing Products
6.4.8 Other Infectious Disease Testing Products
6.5 Coagulation Testing Products
6.5.1 PT/INR Testing Products
6.5.2 Activated Clotting Time (ACT/APTT) Testing Products
6.6 Pregnancy and Fertility Testing Products
6.6.1 Pregnancy Testing Products
6.6.2 Fertility Testing Products
6.7 Tumor/Cancer Marker Testing Products
6.8 Urinalysis Testing Products
6.9 Cholesterol Testing Products
6.10 Hematology Testing Products
6.11 Drugs-of-Abuse Testing Products
6.12 Fecal Occult Testing Products
6.13 Other POC Products

7 Point-of-Care Diagnostics Market, By Platform
7.1 Introduction
7.2 Lateral Flow Assays (Immunochromatography Tests)
7.3 Dipsticks
7.4 Microfluidics
7.5 Molecular Diagnostics
7.6 Immunoassays

8 Point-of-Care Diagnostics Market, By Prescription Mode
8.1 Introduction
8.2 Prescription-Based Testing
8.3 OTC Testing

9 Point-of-Care Diagnostics Market, By End User
9.1 Introduction
9.2 Professional Diagnostic Centers
9.2.1 Clinical Laboratories, Outpatient Healthcare & Ambulatory Care Settings
9.2.2 Hospitals/Critical Care Centers
9.3 Home Care
9.4 Research Laboratories
9.5 Other End Users

10 Point-of-Care Diagnostics Market, By Region
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 France
10.3.3 UK
10.3.4 Rest of Europe (RoE)
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Rest of Asia Pacific
10.5 Rest of the World (RoW)
10.5.1 Latin America
10.5.2 Middle East & Africa

11 Competitive Landscape
11.1 Overview
11.2 Market Share Analysis, 2016
11.3 Competitive Scenario and Trends
11.3.1 Product Launches
11.3.2 Agreements, Partnerships, and Collaborations
11.3.3 Product Approvals
11.3.4 Acquisitions

12 Company Profiles
12.1 Abbott Laboratories
12.2 Accubiotech
12.3 Becton, Dickinson, and Company (BD)
12.4 Chembio Diagnostics
12.5 Danaher Corporation
12.6 EKF Diagnostics
12.7 Instrumentation Laboratory (A Werfen Company)
12.8 Johnson & Johnson
12.9 Nova Biomedical
12.10 PTS Diagnostics (A Part of Sinocare Inc.)
12.11 Quidel
12.12 Roche Diagnostics (A Subsidiary of F. Hoffmann-La Roche Ltd.)
12.13 Sekisui Diagnostics
12.14 Siemens
12.15 Trinity Biotech

13 Appendix
13.1 Discussion Guide
13.2 Knowledge Store: Subscription Portal
13.3 Introducing RT: Real-Time Market Intelligence
13.4 Available Customizations
13.5 Related Reports
13.6 Author Details

List of Tables (129 Tables)

Table 1 Point-of-Care Diagnostics Market, By Product, 2015–2022 (USD Million)
Table 2 Point-of-Care Diagnostics Market for Glucose Monitoring Products, By Type, 2015–2022 (USD Million)
Table 3 Glucose Monitoring Meters Market, By Region, 2015–2022 (Units)
Table 4 Point-of-Care Diagnostics Market for Glucose Monitoring Products, By Region, 2015–2022 (USD Million)
Table 5 Point-of-Care Diagnostics Market for Cardiometabolic Testing Products, By Type, 2015–2022 (USD Million)
Table 6 Point-of-Care Diagnostics Market for Cardiometabolic Testing Products, By Region, 2015–2022 (USD Million)
Table 7 Cardiac Marker Testing Products Market, By Region, 2015–2022 (USD Million)
Table 8 Cardiac Marker Testing Products Market, By Region, 2015–2022 (Units)
Table 9 Blood Gas/Electrolytes Testing Products Market, By Region, 2015–2022 (USD Million)
Table 10 Blood Gas/Electrolytes Testing Analyzers Market, By Region, 2015–2022 (Units)
Table 11 HBA1C Testing Products Market, By Region, 2015–2022 (USD Million)
Table 12 Point-of-Care Diagnostics Market for Infectious Disease Testing Products, By Type, 2015–2022 (USD Million)
Table 13 Point-of-Care Diagnostics Market for Infectious Disease Testing Products, By Region, 2015–2022 (USD Million)
Table 14 Point-of-Care Diagnostics Market for Influenza Testing Products, By Region, 2015–2022 (USD Million)
Table 15 Influenza Testing Analyzers Market, By Region, 2015–2022 (Units)
Table 16 HIV Testing Products Market, By Region, 2015–2022 (USD Million)
Table 17 HIV Testing Analyzers Market, By Region, 2015–2022 (Units)
Table 18 Hepatitis C Testing Products Market, By Region, 2015–2022 (USD Million)
Table 19 Hepatitis C Testing Analyzers Market, By Region, 2015–2022 (Units)
Table 20 STD Testing Products Market, By Region, 2015–2022 (USD Million)
Table 21 Healthcare-Associated Infection Testing Products Market, By Region, 2015–2022 (USD Million)
Table 22 Respiratory Infection Testing Products Market, By Region, 2015–2022 (USD Million)
Table 23 Tropical Disease Testing Products Market, By Region, 2015–2022 (USD Million)
Table 24 Other Infectious Disease Testing Products Market, By Region, 2015–2022 (USD Million)
Table 25 Point-of-Care Diagnostics Market for Coagulation Testing Products, By Type, 2015–2022 (USD Million)
Table 26 Point-of-Care Diagnostics Market for Coagulation Testing Products, By Region, 2015–2022 (USD Million)
Table 27 Coagulation Testing Analyzers Market, By Region, 2015–2022 (Units)
Table 28 PT/INR Testing Products Market, By Region, 2015–2022 (USD Million)
Table 29 ACT/APTT Testing Products Market, By Region, 2015–2022 (USD Million)
Table 30 Point-of-Care Diagnostics Market for Pregnancy and Fertility Testing Products, By Type, 2015–2022 (USD Million)
Table 31 Point-of-Care Diagnostics Market for Pregnancy and Fertility Testing Products, By Region, 2015–2022 (USD Million)
Table 32 Pregnancy Testing Products Market, By Region, 2015–2022 (USD Million)
Table 33 Fertility Testing Products Market, By Region, 2015–2022 (USD Million)
Table 34 Point-of-Care Diagnostics Market for Tumor/Cancer Marker Testing Products, By Region, 2015–2022 (USD Million)
Table 35 Point-of-Care Diagnostics Market for Urinalysis Testing Products, By Region, 2015–2022 (USD Million)
Table 36 Urinalysis Testing Analyzers Market, By Region, 2015–2022 (Units)
Table 37 Point-of-Care Diagnostics Market for Cholesterol Testing Products, By Region, 2015–2022 (USD Million)
Table 38 Cholesterol Testing Analyzers Market, By Region, 2015–2022 (Units)
Table 39 Point-of-Care Diagnostics Market for Hematology Testing Products, By Region, 2015–2022 (USD Million)
Table 40 Hematology Testing Analyzers Market, By Region, 2015–2022 (Units)
Table 41 Point-of-Care Diagnostics Market for Drugs-of-Abuse Testing Products, By Region, 2015–2022 (USD Million)
Table 42 Point-of-Care Diagnostics Market for Fecal Occult Testing Products, By Region, 2015–2022 (USD Million)
Table 43 Point-of-Care Diagnostics Market for Other POC Products, By Region, 2015–2022 (USD Million)
Table 44 POC Diagnostics Market, By Platform, 2015–2022 (USD Million)
Table 45 Point-of-Care Diagnostics Market, By Prescription Mode, 2015–2022 (USD Million)
Table 46 Prescription-Based Testing Market, By Region, 2015–2022 (USD Million)
Table 47 OTC Testing Products Market, By Region, 2015–2022 (USD Million)
Table 48 Point-of-Care Diagnostics Market, By End User, 2015–2022 (USD Million)
Table 49 Point-of-Care Diagnostics Market for Professional Diagnostic Centers, By Type, 2015–2022 (USD Million)
Table 50 Point-of-Care Diagnostics Market for Professional Diagnostic Centers, By Region, 2015–2022 (USD Million)
Table 51 Point-of-Care Diagnostics Market for Clinical Laboratories, Outpatient Healthcare & Ambulatory Care Settings, By Region, 2015–2022 (USD Million)
Table 52 Point-of-Care Diagnostics Market for Hospitals/Critical Care Centers, By Region, 2015–2022 (USD Million)
Table 53 Point-of-Care Market for Home Care, By Region, 2015–2022 (USD Million)
Table 54 Point-of-Care Diagnostics Market for Research Laboratories, By Region, 2015–2022 (USD Million)
Table 55 Point-of-Care Diagnostics Market for Other End Users, By Region, 2015–2022 (USD Million)
Table 56 Point-of-Care Diagnostics Market, By Region, 2015–2022 (USD Million)
Table 57 North America: Point-of-Care Diagnostics Market, By Country, 2015–2022 (USD Million)
Table 58 North America: Point-of-Care Diagnostics Market, By Product, 2015–2022 (USD Million)
Table 59 North America: Point-of-Care Diagnostics Market, By Prescription Mode, 2015–2022 (USD Million)
Table 60 North America: Point-of-Care Diagnostics Market, By End User, 2015–2022 (USD Million)
Table 61 US: Point-of-Care Diagnostics Market, By Product, 2015–2022 (USD Million)
Table 62 US: Point-of-Care Diagnostics Market, By Prescription Mode, 2015–2022 (USD Million)
Table 63 US: Point-of-Care Diagnostics Market, By End User, 2015–2022 (USD Million)
Table 64 Canada: Point-of-Care Diagnostics Market, By Product, 2015–2022 (USD Million)
Table 65 Canada: Point-of-Care Diagnostics Market, By Prescription Mode, 2015–2022 (USD Million)
Table 66 Canada: Point-of-Care Diagnostics Market, By Platform, 2015–2022 (USD Million)
Table 67 Canada: Point-of-Care Diagnostics Market, By End User, 2015–2022 (USD Million)
Table 68 Europe: Point-of-Care Diagnostics Market, By Country, 2015–2022 (USD Million)
Table 69 Europe: Point-of-Care Diagnostics Market, By Prescription Mode, 2015–2022 (USD Million)
Table 70 Europe: Point-of-Care Diagnostics Market, By End User, 2015–2022 (USD Million)
Table 71 Germany: Point-of-Care Diagnostics Market, By Product, 2015–2022 (USD Million)
Table 72 Germany: Point-of-Care Diagnostics Market, By Prescription Mode, 2015–2022 (USD Million)
Table 73 Germany: Point-of-Care Diagnostics Market, By End User, 2015–2022 (USD Million)
Table 74 France: Point-of-Care Diagnostics Market, By Product, 2015–2022 (USD Million)
Table 75 France: Point-of-Care Diagnostics Market, By Prescription Mode, 2015–2022 (USD Million)
Table 76 France: Point-of-Care Diagnostics Market, By End User, 2015–2022 (USD Million)
Table 77 UK: Point-of-Care Diagnostics Market, By Product, 2015–2022 (USD Million)
Table 78 UK: Point-of-Care Diagnostics Market, By Prescription Mode, 2015–2022 (USD Million)
Table 79 UK: Point-of-Care Diagnostics Market, By End User, 2015–2022 (USD Million)
Table 80 RoE: Point-of-Care Diagnostics Market, By Product, 2015–2022 (USD Million)
Table 81 RoE: Point-of-Care Diagnostics Market, By Prescription Mode, 2015–2022 (USD Million)
Table 82 RoE: Point-of-Care Diagnostics Market, By End User, 2015–2022 (USD Million)
Table 83 APAC: Point-of-Care Diagnostics Market, By Country, 2015–2022 (USD Million)
Table 84 APAC: Point-of-Care Diagnostics Market, By Product, 2015–2022 (USD Million)
Table 85 APAC: Point-of-Care Diagnostics Market, By Prescription Mode, 2015–2022 (USD Million)
Table 86 APAC: Point-of-Care Diagnostics Market, By End User, 2015–2022 (USD Million)
Table 87 Japan: Point-of-Care Diagnostics Market, By Product, 2015–2022 (USD Million)
Table 88 Japan: Point-of-Care Diagnostics Market, By Prescription Mode, 2015–2022 (USD Million)
Table 89 Japan: Point-of-Care Diagnostics Market, By End User, 2015–2022 (USD Million)
Table 90 China: Point-of-Care Diagnostics Market, By Product, 2015–2022 (USD Million)
Table 91 China: Point-of-Care Diagnostics Market, By Prescription Mode, 2015–2022 (USD Million)
Table 92 China: Point-of-Care Diagnostics Market, By End User, 2015–2022 (USD Million)
Table 93 India: Point-of-Care Diagnostics Market, By Product, 2015–2022 (USD Million)
Table 94 India: Point-of-Care Diagnostics Market, By Prescription Mode, 2015-2022 (USD Million)
Table 95 India: Point-of-Care Diagnostics Market, By End User, 2015–2022 (USD Million)
Table 96 RoAPAC: Point-of-Care Diagnostics Market, By Product, 2015–2022 (USD Million)
Table 97 RoAPAC: Point-of-Care Diagnostics Market, By Prescription Mode, 2015–2022 (USD Million)
Table 98 RoAPAC: Point-of-Care Diagnostics Market, By End User, 2015–2022 (USD Million)
Table 99 RoW: Point-of-Care Diagnostics Market, By Country, 2015–2022 (USD Million)
Table 100 RoW: Point-of-Care Diagnostics Market, By Product, 2015–2022 (USD Million)
Table 101 RoW: Point-of-Care Diagnostics Market, By Prescription Mode, 2015–2022 (USD Million)
Table 102 RoW: Point-of-Care Diagnostics Market, By End User, 2015–2022 (USD Million)
Table 103 Latin America: Point-of-Care Diagnostics Market, By Product, 2015–2022 (USD Million)
Table 104 Latin America: Point-of-Care Diagnostics Market, By Prescription Mode, 2015–2022 (USD Million)
Table 105 Latin America: Point-of-Care Diagnostics Market, By End User, 2015–2022 (USD Million)
Table 106 Middle East & Africa: Point-of-Care Diagnostics Market, By Product, 2015–2022 (USD Million)
Table 107 Middle East & Africa: Point-of-Care Diagnostics Market, By Prescription Mode, 2015–2022 (USD Million)
Table 108 Middle East & Africa: Point-of-Care Diagnostics Market, By End User, 2015–2022 (USD Million)

List of Figures (36 Figures)

Figure 1 Research Methodology Steps
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Data Triangulation
Figure 4 Global Point-of-Care Diagnostics Market, By Product, 2017 vs 2022
Figure 5 Global Point-of-Care Diagnostics Market, By Prescription Mode, 2017 vs 2022
Figure 6 Global Point-of-Care Diagnostics Market, By Platform, 2017 vs 2022
Figure 7 Global Point-of-Care Diagnostics Market, By End User, 2017 vs 2022
Figure 8 Global Point-of-Care Diagnostics Market, By Region, 2017 (USD Million)
Figure 9 High Prevalence of Infectious Diseases is Driving the Adoption of POC Devices Across the Globe
Figure 10 Lateral Flow Assays Segment Will Continue to Dominate the Market in 2022
Figure 11 Professional Diagnostic Centers Segment to Dominate the Global POC Diagnostics End-User Market in 2017
Figure 12 Glucose Monitoring Segment to Dominate the POC Diagnostics Products Market During the Forecast Period
Figure 13 Prescription-Based Testing Products to Dominate the POC Diagnostics Market During the Forecast Period
Figure 14 North America to Register the Highest CAGR During the Forecast Period
Figure 15 POC Diagnostics Market: Drivers, Restraints, Opportunities, and Challenges
Figure 16 Estimated Number of Diabetic Patients, By Region, 2015 vs 2040
Figure 17 The Infectious Disease Testing Products Segment is Projected to Grow at the Highest CAGR During the Forecast Period
Figure 18 Molecular Diagnostics Segment to Witness Highest Growth Rate During the Forecast Period
Figure 19 OTC Testing Segment to Witness Higher Growth During the Forecast Period
Figure 20 Home Care to Witness Highest Growth During the Forecast Period
Figure 21 Point-of-Care Diagnostics Market: Growth Forecast, By Region (2017–2022)
Figure 22 North America: Point-of-Care Diagnostics Market Snapshot
Figure 23 Europe: Point-of-Care Diagnostics Market Snapshot
Figure 24 APAC: Point-of-Care Diagnostics Market Snapshot
Figure 25 Key Developments By Leading Market Players in the Market, 2015–2017
Figure 26 Point-of-Care Diagnostics Market Share, By Key Players, 2016
Figure 27 Abbott Laboratories: Company Snapshot
Figure 28 BD: Company Snapshot
Figure 29 Chembio Diagnostics: Company Snapshot
Figure 30 Danaher Corporation: Company Snapshot
Figure 31 EKF Diagnostics: Company Snapshot
Figure 32 Johnson & Johnson: Company Snapshot
Figure 33 Quidel: Company Snapshot
Figure 34 Roche Diagnostics: Company Snapshot
Figure 35 Siemens: Company Snapshot
Figure 36 Trinity Biotech: Company Snapshot

Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
5 of 5
  • Abbott
  • AccuBioTech
  • and Company
  • Becton
  • Chembio
  • Danaher
  • Dickinson
  • EKF Diagnostics
  • Instrumentation Laboratory
  • Johnson & Johnson
  • Nova
  • PTS Diagnostics
  • Quidel
  • Roche
  • Sekisui Diagnostics
  • Siemens
  • Trinity Biotech
Note: Product cover images may vary from those shown
Adroll
adroll